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Cardiac Output Is Not Related to the Slowed
O2 Uptake Kinetics in Type 2 Diabetes
OSCAR MAC ANANEY1, JOHN MALONE1, STUART WARMINGTON2, DONAL O’SHEA3, SIMON GREEN4,
and MIKEL EGAÑA1
Department of Physiology, Trinity College Dublin, Dublin, IRELAND; 2Centre for Physical Activity and Nutrition
Research, School of Exercise and Nutrition Sciences, Deakin University, Victoria, AUSTRALIA; 3Endocrinology,
St. Columcilles and St. Vincent’s Hospitals Co., Dublin, IRELAND; and 4Department of Physiology, University of Otago,
Dunedin, NEW ZEALAND
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ABSTRACT
MAC ANANEY, O., J. MALONE, S. WARMINGTON, D. O’SHEA, S. GREEN, and M. EGAÑA. Cardiac Output Is Not Related to the
Slowed O2 Uptake Kinetics in Type 2 Diabetes. Med. Sci. Sports Exerc., Vol. 43, No. 6, pp. 935–942, 2011. Purpose: This study aimed
to investigate whether cardiac output (CO) responses were related to V̇O2 kinetics during cycling in type 2 diabetes. Methods: A total of
9 middle-aged women with uncomplicated type 2 diabetes, 9 nondiabetic overweight women, and 11 nondiabetic lean women were
recruited. Initially, the ventilatory threshold (VT) and peak V̇O2 were determined during a maximal graded test. Then, on two separate
days, subjects completed three 7-min bouts of constant-load cycling at each of three intensities: 50% VT, 80% VT, and midpoint between
VT and peak V̇O2 (50% $). CO (inert gas rebreathing) was recorded at 30 and 240 s of an additional bout at each intensity. V̇O2 kinetic
parameters were determined by fitting a biexponential (50% VT and 80% VT) or triexponential (50% $) function to the V̇O2 data.
Results: Peak V̇O2 was significantly lower in type 2 diabetes compared with the two nondiabetic groups (P G 0.05). The time constant of
phase 2 was significantly greater (P G 0.05) in type 2 diabetes compared with the nondiabetic heavy and lean groups at 50% VT (34.2 T
15.7 vs 15.4 T 7.3 and 20.2 T 9.7 s) and 80% VT (39.1 T 9.0 vs 24.8 T 8.8 and 36.8 T 7.9 s), but none of the V̇O2 kinetic parameters were
different at 50% $. CO responses during exercise were not different among the three groups, and at 80% VT, the change in CO from 30
to 240 s was significantly larger in type 2 diabetes compared with the two nondiabetic groups. Conclusions: The results confirm that type
2 diabetes slows the dynamic response of V̇O2 during light and moderate relative intensity exercise in females but that this occurs in the
absence of any slowing of the CO response during the initial period of exercise. Key Words: CARDIAC OUTPUT, O2 UPTAKE
KINETICS, TYPE 2 DIABETES, WOMEN, CYCLING

S

ubjects with type 2 diabetes exhibit exercise intolerance (2,20,23,25) that is associated with an increased
risk of mortality (30). The cause of exercise intolerance in diabetes is not well understood, but peak oxygen
uptake (V̇O2) has consistently been shown to be reduced
in type 2 diabetic subjects compared with healthy control
subjects matched for age, weight, and activity levels
(2,18,23–25,28). In addition, pulmonary V̇O2 has been reported to adjust more slowly during the early period of
exercise (i.e., slower V̇O2 kinetics) in type 2 diabetes com-

pared with nondiabetic controls during submaximal cycling
exercise (4,7,23).
Slowing of the dynamic response of V̇O2 during submaximal exercise might increase fatigue and contribute to exercise intolerance (13). The control of V̇O2 during the initial
period of exercise depends on the control of blood flow (O2
delivery) to, and control of O2 consumption by, the contracting muscles. To our knowledge, there are no data on the
dynamic response of either cardiac output (CO) or muscle
blood flow during exercise in humans with type 2 diabetes. In
streptozodocin-induced rats (a type 2 diabetes model), the
decline in muscle microvascular PO2 observed during the first
60 s of intermittent contractions (1 Hz) was more rapid than
in control animals (6). Similarly, the near-infrared spectroscopy (NIRS)–measured concentrations of oxygenated and
deoxygenated hemoglobin/myoglobin ([HHb]) of the thigh
muscle showed a transient ‘‘overshoot’’ at the onset of moderate cycling exercise above the level achieved for steady
state in humans with type 2 diabetes but not in healthy controls (4). In the same study, the microvascular blood flow
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responses, estimated from simultaneously measured NIRSderived [HHb] signals and pulmonary V̇O2 responses, were
significantly slower in subjects with type 2 diabetes compared
with healthy controls (4). Both of these observations (4,6)
suggest that the rate of O2 delivery is slowed relative to
the rate of O2 consumption by contracting muscle in type
2 diabetes.
Steady-state measurements provide a more conflicting
picture of this problem. Lower limb blood flow measured
after several minutes of submaximal cycling was blunted in
subjects with type 2 diabetes (17). In contrast, both CO and
arteriovenous O2 difference (a-v O2) measured after 5 min of
submaximal cycling were similar between diabetic subjects
and healthy controls (2). However, none of these findings
shed light on the rate of cardiovascular adjustments before
the achievement of a steady state. To explore this further, the
aim of the present study was to test the hypothesis that the
dynamic responses of CO and oxygen uptake are slowed in
type 2 diabetes. Because the effect of type 2 diabetes on V̇O2
kinetics might depend on the intensity of exercise (4,7,23),
this hypothesis was tested at three submaximal workloads.

METHODS
Subjects. Unless otherwise stated, all experimental procedures were completed within the Department of Physiology, Trinity College Dublin, after approval by the Faculty of
Health Sciences Research Ethics Committee in accordance
with the Declaration of Helsinki. After providing written
informed consent, 29 female subjects were recruited into
the following three groups according to specific inclusion/
exclusion criteria: patients being treated for type 2 diabetes
mellitus (n = 9); overweight but otherwise healthy controls
(‘‘heavy controls,’’ n = 9); and lean and healthy controls
(‘‘lean controls,’’ n = 11; Table 1).
Subjects with type 2 diabetes were recruited in consultation with, and were all receiving treatment for diabetes at,
St. Columcilles Hospital, Dublin. Healthy subjects were recruited from Trinity College Dublin. All subjects were free
of signs, symptoms, and clinical evidence of coronary or
peripheral arterial disease, neuropathy, or retinopathy. They
were nonsmokers and had not smoked during the 12-month
period preceding the study. None of the subjects were taking
insulin, A-blockers, calcium channel blockers, or any other
antihypertensive drugs. None of the control subjects were
TABLE 1. Mean (TSD) physical and hematological characteristics for the three groups
of subjects.
Type 2 Diabetes
Age (yr)
Height (cm)
Body mass (kg)
BMI (kgImj2)
Glucose (mmolILj1)
HbA1c (%)
Insulin (mUILj1)

49.1
165
94.0
34.4
8.1
6.8
12.3

T
T
T
T
T
T
T

5.7
7
22.8*
7.4*
1.7*,**
1.0*,**
4.8*

Heavy Controls
42.5
162
77.4
29.0
5.5
5.1
8.3

T
T
T
T
T
T
T

12.6
8
8.7*
8.7*
0.4
0.4
1.0

Lean Controls
44.1
165
63.6
22.7
4.6
5.3
6.8

T
T
T
T
T
T
T

8.2
10
16.7
1.2
0.5
0.3
1.5

* Significantly different (P G 0.05) from the lean group.
** Significantly different (P G 0.05) from the heavy group.
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on prescriptive medication. However, diabetic subjects were
taking oral hypoglycemic prescription drugs (metformin,
n = 5; rosiglitazone, n = 1), statins (n = 3), and an angiotensinconverting enzyme inhibitor (n = 1) and/or were undergoing
dietary control of their diabetes. All diabetic subjects had a
clinical history of diabetes of 1–5 yr. They were prescreened
by the treating physicians to confirm that blood pressure was
normal and that there was no kidney dysfunction (consistent
urinary protein G 200 mgIdLj1) or liver dysfunction (urinary
creatinine levels G 2.2 mgIdLj1). In addition, there was no
clinical evidence of ischemic heart disease based on a 12-lead
EKG response during a standard treadmill stress test.
All subjects were sedentary (G1 hIwkj1 of moderateintensity exercise) for at least 3 months before the study, and
this was confirmed after completion of the Low-Level Physical Activity Recall questionnaire (19,26). Subjects were required to refrain from taking alcohol, caffeine, and exercise
in the 12 h preceding each testing session (see below).
Experimental protocol. Each subject attended the
laboratory on three separate days for testing. Given that
some subjects were premenopausal (n = 11: 4 diabetic, 4
heavy controls, and 3 lean controls), testing sessions for all
subjects were separated by between 48 and 72 h to complete
all testing within 8 d, and this was aligned with the midfollicular phase of the menstrual cycle (days 5–12) for the
premenopausal subjects. None of the subjects were taking
contraceptive drugs or receiving hormone replacement therapy during or 6 months before the testing period.
On all testing days, exercise was performed on an electrically braked cycle ergometer (Excalibur Sport; Lode,
Groningen, The Netherlands). Subjects wore an HR monitor
(S725x; Polar Electro Oy, Kempele, Finland) to continuously record HR every 5 s at rest and during exercise. In
addition, subjects wore a silicon facemask (7900 series; Hans
Rudolph, Kansas City, MO) for continuous analysis of expired gases on a breath-by-breath basis using an online metabolic system (Innocor; Innovision A/S, Odense, Denmark).
Analysis of expired air allowed determination of oxygen
uptake (V̇O2), carbon dioxide production (V̇CO2), minute
ventilation (V̇E), and the RER during all rest and exercise
periods. This system also enabled the measurement of CO
at specific time points via a rebreathing technique (see below
for description).
On testing day 1, subjects completed a graded cycle test
to fatigue. After 3 min of rest, subjects cycled at an initial
workload of 40 W for 3 min before the workload was increased by 20 W every 3 min until a cadence of 60 rpm
could not be maintained (i.e., task failure). The peak workload achieved was defined as the highest workload able to
be maintained for at least 1 min. From this test, the workload at which the ventilatory threshold (VT) occurred was
determined using the V slope method by identifying the
power output at which a clear steeper increase of V̇CO2 as
compared with V̇O2 occurs (1,5).
On testing days 2 and 3, subjects were required to complete six 7-min exercise bouts on each day, so that during the
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q
q
VO2 ðt Þ ¼ baseline VO2 þ A1 1  eðtTD1 Þ=T1 U1


þ A2 1  eðtTD2 Þ=T2 U2
½1


q
q
VO2 ðt Þ ¼ baseline VO2 þ A1 1  eðtTD1 Þ=T1 U1




þ A2 1  eðtTD2 Þ=T2 U2 þ A3 1  eðtTD3 Þ=T3 U3 ½2

The three exponential terms represent the ‘‘cardiodynamic,’’
‘‘fast,’’ and ‘‘slow’’ components of the V̇O2 response to exercise. Baseline V̇O2 represents oxygen uptake during the
initial 3-min rest period of each exercise bout; and for each
exponential term, A1, A2, and A3 are the asymptotic amplitudes; T1, T2, and T3 are the time constants; and TD1, TD2,
and TD3 are the time delays. The parameters U1, U2, and U3
are conditional expressions that limit the fitting of a particular phase to the period at and beyond the time delay associated with that phase. The models were fitted to the data
using a weighted least-squares nonlinear regression procedure
(TableCurve 2D; Systat, Chicago, IL). Data that exceeded the
95% prediction intervals during an initial fit of a model were
excluded. The investigator who performed the curve fitting
procedure was blinded with respect to patient identification.
The mean response time (MRT) that represents the time to
reach 63% of the overall amplitude of the response from
baseline was calculated as a weighted sum of the time delay

CO AND O2 UPTAKE KINETICS IN DIABETES

and time constant of each phase. The equation used for 50%
VT and 80% VT can be seen below (equation 3):
MRT ¼ ½A1 =ðA1 þ A2 ÞðTD1 þ T1 Þ þ ½A2 =ðA1 þ A2 ÞðTD2 þ T2 Þ

½3

For 50% $ MRT was calculated as follows (equation 4):
MRT ¼ ½A1 =ðA1 þ A2 þ A3 ÞðTD1 þ T1 Þ
þ ½A2 =ðA1 þ A2 þ A3 ÞðTD2 þ T2 Þ
þ ½A3 =ðA1 þ A2 þ A3 ÞðTD3 þ T3 Þ

½4

HR was measured at rest and every 5 s during each of the
three constant-load cycling exercise trials at each intensity
and averaged to yield a single time series of HR data for each
subject at each intensity. The dynamic structures of the HR
responses were not as consistent between subjects as the
oxygen uptake responses, so a relatively simpler, monoexponential function was chosen to fit HR responses (equation 5),


heart rate ¼ a þ A 1  eðtTDÞ=T

½5

where a is the baseline HR, A is the amplitude of the exercise response, TD is the delay in rise of HR after exercise
onset, and T is the time constant of the response. The fitting
procedures were identical with that described for oxygen
uptake.
CO. CO was measured using an inert gas (sulfur hexafluoride (SF6) and nitrous oxide (N2O)) rebreathing technique based on the Fick principle, as previously described
(14). This was performed during the final exercise bout only
on testing day 3, but at two time points (at 30 and 240 s)
during each 7-min exercise period at each intensity. In brief,
subjects were required to initially inspire an entire bolus
volume (40% predicted vital capacity) of the test gas mixture
contained within a rubber bag connected to the Innocor respiratory valve assembly. A preset respiratory rate (20 breaths
per minute) was required to be maintained in synchrony with
the visual display on the Innocor screen during continuous
rebreathing with the rubber bag until equilibration of gas
concentrations was apparent. This usually occurred within
four to five breaths (approximately 15–20 s). From each maneuver, pulmonary blood flow (CO) was determined, and in
conjunction with the continuous HR record, stroke volume
(SV) was calculated (CO/HR). The a-v O2 difference was
calculated as V̇O2/CO. Recent unpublished data from our
laboratory revealed that the device provides highly reproducible responses when the same subjects (both subjects with
diabetes n = 7 and subjects without diabetes n = 10) perform
the same CO measurements at 30 and 240 s during three
exercise bouts (at 50% VT, 80% VT, and 50% $) completed
on two to three occasions (coefficient of variation ~5%).
Before the exercise on testing day 3, subjects were familiarized with the rebreathing technique by completing the
maneuver up to 5 times in ‘‘demo’’ mode, which simulates the
rebreathing technique without utilizing the test gas. Subjects
then completed a further two ‘‘live’’ maneuver to determine
resting CO before beginning the exercise bouts. Technical
difficulties precluded the recording of CO in two diabetic
participants.
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2 d, each subject completed four exercise bouts at each of the
following three intensities relative to the workloads achieved
at VT and peak V̇O2 as defined by the graded test performed
on day 1:50% VT, 80% VT, and midpoint between VT and
peak workload (50% $). Exercise bouts were completed in
a sequence of three, beginning with 3-min rest followed by
7-min cycling at 50% VT, then 10-min rest followed by 7-min
cycling at 80% VT, then 15-min rest followed by 7-min
cycling at 50% $. Subjects then rested for 45 min, after
which the exercise sequence was repeated. The entire session
(i.e., six bouts) was then replicated on testing day 3. Previous
data suggest the rest periods used are sufficient for HR and
blood lactate to return to resting levels (3,8,31).
The initial three bouts at each of the three intensities were
used to determine oxygen uptake kinetics, and the fourth
bout at each intensity was used for determination of CO
responses (see below).
Oxygen uptake and HR kinetics. Kinetics of oxygen uptake were determined for each constant-load exercise
intensity using the breath-by-breath V̇O2 data collected during the first three 7-min exercising periods at each intensity.
Data were linearly interpolated to 1-s intervals, time aligned
to the onset of exercise, and then an average data set determined for each subject at each intensity. The data set was
then smoothed using a 5-s moving average filter. Kinetic
parameters were determined by fitting a two-component exponential curve to the results for the exercise intensities
below the ventilatory threshold (50% VT and 80% VT; see
equation 1) while fitting a three-component exponential curve
to the results for the exercise intensity above the ventilatory
threshold (50% $; see equation 2).

CLINICAL SCIENCES

Statistical analyses. Peak physiological responses
and kinetic parameters were compared at rest and during
exercise among the three groups using a one-way ANOVA
(Sigma Stat, Systat). A two-way repeated-measures ANOVA
(group  time) was used to compare cardiac responses during
constant-load cycle exercise bouts. Differences were located
using Tukey post hoc test. Data that were not normally distributed were analyzed using Kruskal–Wallis test, and multiple comparisons were then performed using Dunn method.
The level of significance was set as P e 0.05. All values are
expressed as mean T SD.

RESULTS
Graded test. Exercise times and peak physiological
responses for the three groups during the graded test are
shown in Table 2. Peak V̇O2 (LIminj1; mLIkgj1Iminj1) and
the workload at VT were lower in the group with type 2
diabetes compared with the control groups (P G 0.05). The
workload at VT relative to peak workload and peak V̇O2 was
not different among groups (68% T 13% and 78% T 6% type
2 diabetes, 72% T 10% and 77% T 7% heavy controls, and
73% T 10% and 77% T 8% lean controls). In addition, peak
V̇O2 (mLIkgj1Iminj1) was lower in the heavy control compared with the lean control group (P G 0.05). Peak HR and
peak workload were lower in the group with type 2 diabetes
compared with the lean group but not different compared
with the heavy group (P G 0.05). No differences in peak RER
were observed among the three groups.
Cardiac responses to constant-load exercise.
Cardiac responses obtained at rest and during constant-load
exercise (30 and 240 s) for the three groups and three intensities can be seen in Figure 1. At rest and during exercise
intensities equivalent to 50% VT, cardiac responses were
not different among the three groups. At 80% VT, SV was
higher in subjects with type 2 diabetes at 240 s compared
with the lean and heavy controls (P G 0.05), and the changes
of CO and SV index from 30 to 240 s of exercise were
significantly larger in the group with type 2 diabetes than the
lean and heavy control groups. In addition, the changes of
CI and SV were also larger from 30 to 240 s in the diabetic
compared with the heavy control group. When cycling at
heavy exercise intensities, HR was higher in the lean group

TABLE 2. Mean (TSD) peak physiological responses from the graded test for the three
groups of subjects.
Type 2
Diabetes
Peak V̇O2 (LIminj1)
Peak V̇O2 (mLIminj1Ikgj1)
Peak HR (bpm)
Peak Wload (W)
Wload at VT (W)
V̇O2 at VT (mLIminj1Ikgj1)
Peak RER

1.40
15.5
145
91
61
12.1
1.13

T
T
T
T
T
T
T

0.26*,**
4.4*,**
20*
23*
14*,**
3.1*,**
0.06

Heavy
Controls
1.77
22.7
165
124
90
17.5
1.12

T
T
T
T
T
T
T

0.22
2.6*
19
28
21
2.0
0.06

Lean
Controls
1.73
27.1
173
133
97
20.9
1.10

T
T
T
T
T
T
T

0.30
4.3
17
34
26
3.5
0.08

* Significantly different (P G 0.05) from the lean group.
** Significantly different (P G 0.05) from the heavy group.
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at 240 s compared with both the group with type 2 diabetes
and heavy control group (P G 0.05).
Oxygen uptake and HR kinetic responses to
constant-load exercise. Parameters describing O2 kinetics during the three workloads are shown in Table 3. V̇O2
responses during exercise at 50% VT in a diabetic, heavy
control, and lean control subject are shown in Figure 2. The
time constant for the second phase (T2) of the V̇O2 response
was slower in type 2 diabetes compared with the control
groups at intensities relative to 50% VT and 80% VT. The
MRT for V̇O2 was slower in type 2 diabetes compared with
the heavy and lean control groups at 50% VT. MRT was
also slower in type 2 diabetes compared with the heavy
control group, but not the lean control group, at 80% VT.
The time delay for phase 1 (TD1) at 50% VT was greater for
the heavy and lean control groups compared with the group
with type 2 diabetes.
There were no significant differences in parameters that
describe the dynamics of the HR response among these three
groups (type 2 diabetes vs heavy vs lean), at any of the three
intensities, including the time constant (parameter T; 50%
VT = 37.9 T 20.1 vs 25.7 T 11.5 vs 31.2 T 18.5 s; 80% VT =
55.1 T 22.1 vs 36.4 T 17.1 vs 60.3 T 40.1 s; 50% $ = 65.0 T
20.5 vs 68.1 T 15.3 vs 71.0 T 31.5 s).
DISCUSSION
There were two important findings in this study. First,
V̇O2 kinetic responses were slowed during constant-load
cycling exercise at light and moderate exercise intensities
in females with uncomplicated type 2 diabetes compared
with nondiabetic lean and heavy controls, confirming previous findings (4,7,23). Second, simultaneous measurements of
CO responses at the three constant-load cycling exercise intensities were similar among the three groups, whereas the
change in CO during the period of the fast phase of V̇O2 was
manifest as greater, rather than smaller, in type 2 diabetes
at the moderate intensity. These findings suggest that the
slowing of V̇O2 kinetics in type 2 diabetes is not due to an
impaired response of CO.
Peak oxygen uptake. Subjects with type 2 diabetes
exhibit exercise intolerance (2,20,23,25) that is associated
with an ~20% reduction in peak V̇O2 compared with healthy
subjects of similar age, weight, and activity levels (2,18,
23–25,28). The present findings of a 20% lower peak V̇O2
in the presence of slowed V̇O2 kinetics are in agreement
with other data.
Oxygen uptake kinetics. Understanding the control
of the dynamic response of V̇O2 in diabetes is important as
slowing of this response might be linked to increased fatigue
during exercise and exercise intolerance (13). This V̇O2 response consists of at least two to three phases (22). At light
to moderate intensities (GVT), two phases are observed,
whereas at higher intensities above VT and below peak
V̇O2, an additional ‘‘slow’’ phase is manifest (10). The second and third of these phases are particularly relevant

http://www.acsm-msse.org

Copyright © 2011 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.

CLINICAL SCIENCES
FIGURE 1—CO, cardiac index, SV, stroke volume index, and a-v O2 difference during cycling exercise at 50% VT, 80% VT, and 50% $ in type 2
diabetes, heavy controls, and lean controls. *Significantly different (P G 0.05) from the lean group. †Significantly different (P G 0.05) from the heavy group.
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TABLE 3. Mean (TSD) dynamic response characteristics of oxygen uptake during
cycling exercise at 50% VT, 80% VT, and 50% $ in type 2 diabetes, heavy controls, and
lean controls.
Type 2 Diabetes
50% VT
Baseline V̇O2 (LIminj1)
A1 (LIminj1)
TD1 (s)
T1 (s)
A2 (LIminj1)
TD2 (s)
T2 (s)
A420 (LIminj1)
MRT (s)
80% VT
Baseline V̇O2 (LIminj1)
A1 (LIminj1)
TD1 (s)
T1 (s)
A2 (LIminj1)
TD2 (s)
T2 (s)
A420 (LIminj1)
MRT (s)
50% $
Baseline V̇O2 (LIminj1)
A1 (LIminj1)
TD1 (s)
T1 (s)
A2 (LIminj1)
TD2 (s)
T2 (s)
A3 (LIminj1)
TD3 (s)
T3 (s)
A420 (LIminj1)
MRT (s)

Heavy Controls

Lean Controls

0.34
0.30
2.3
5.9
0.34
36.0
34.2
0.98
40.7

T
T
T
T
T
T
T
T
T

0.09
0.12
3.3
3.4
0.12
12.4
15.7*,**
0.22
9.2*,**

0.29
0.29
3.7
5.0
0.30
27.4
15.4
0.88
25.6

T
T
T
T
T
T
T
T
T

0.06
0.16
4.5
4.7
0.11
11.1
7.3
0.16
6.6

0.28
0.33
5.1
5.5
0.34
32.5
20.2
0.95
32.1

T
T
T
T
T
T
T
T
T

0.10
0.11
3.9
3.8
0.10
8.7
9.7
0.24
5.2

0.33
0.31
1.4
5.0
0.51
23.9
39.1
1.16
41.1

T
T
T
T
T
T
T
T
T

0.09
0.12
2.1*
5.4
0.15
8.8
9.0*,**
0.19
5.9**

0.31
0.41
5.0
3.5
0.47
30.8
24.8
1.19
33.2

T
T
T
T
T
T
T
T
T

0.08
0.12
3.5
1.7
0.20
8.9
8.8
0.22
4.5

0.31
0.44
6.0
6.6
0.49
32.5
26.8
1.24
36.8

T
T
T
T
T
T
T
T
T

0.11
0.15
4.6
2.6
0.22
10.6
10.4
0.32
7.9

0.33
0.42
4.8
6.5
0.56
33.4
22.1
0.14
140.0
139.9
1.48
65.4

T
T
T
T
T
T
T
T
T
T
T
T

0.08
0.15
6.2
5.0
0.32
10.0
12.2
0.05
33.0
167.8
0.33
24.8

0.32
0.49
7.0
5.5
0.65
32.0
21.1
0.14
141.6
83.2
1.60
56.7

T
T
T
T
T
T
T
T
T
T
T
T

0.05
0.11
5.4
4.6
0.24
8.7
6.2
0.06
38.2
65.0
0.28
15.6

0.35
0.47
5.0
8.5
0.84
26.8
24.1
0.19
148.4
84.6
1.71
61.2

T
T
T
T
T
T
T
T
T
T
T
T

0.13
0.09
4.0
6.2
0.27
14.0
10.2
0.09
23.3
45.0
0.39
11.9

See Methods for further description.
* Significantly different (P G 0.05) from the lean group.
* Significantly different (P G 0.05) from the heavy group.

because they reflect oxygen consumption by active muscle
(11). Accurate interpretation of the effect of type 2 diabetes
on the dynamic response of V̇O2 depends on an accurate
description of these phases. Inaccurate description of the
structure of a dynamic response (e.g., the number of phases)
leads to large errors in estimating time constants and erroneous conclusions about the ‘‘kinetics’’ of the response (21).
A limitation with two of the three previous studies of V̇O2
kinetics in type 2 diabetes (7,23) is the assumption that the
V̇O2 response during a 3- to 6-min bout of submaximal exercise was monophasic. Although a larger time constant of
this single-phase response was observed at low and moderate
intensities in type 2 diabetes (7,23), suggesting that the
overall V̇O2 response is slowed, the real response is at least
biphasic, and so it is not clear which of these two phases is
slowed.
In the present study, biphasic and triphasic functions were
fitted to responses at low to moderate and high intensities,
respectively. At the low and moderate intensity, a larger time
constant for phase 2 of the V̇O2 response in type 2 diabetes
clearly demonstrates a slowing of the ‘‘kinetic’’ response of
this phase. This is consistent with more recent evidence of a
slowing of phase 2 at an intensity below the ‘‘lactate threshold’’ (4). Collectively, these data show that the slowed ad-
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justment of V̇O2 during the early period of exercise in type
2 diabetes, represented by a larger mean response time, is
focused on phase 2. Because this phase is attributed almost
entirely to O2 consumption by contracting muscle (11), these
data confirm that type 2 diabetes results in a slowing of the
initial adjustment of muscle V̇O2 during exercise.
However, at the highest intensity, the time constant of
phase 2 was similar among the three groups. This is also
consistent with earlier evidence of no slowing of the overall
V̇O2 response (monophasic) in type 2 diabetes at a relatively
high intensity (23). In the absence of other physiological
data, this intensity-dependent effect of type 2 diabetes on
V̇O2 kinetics is difficult to explain.
Mechanisms for the slowed oxygen uptake
kinetics. On the basis of the Fick equation for V̇O2,
the control of V̇O2 depends on the control of blood flow
and a-v O2. Blood flow could be limited by poor pumping
capacity and/or impaired vasodilation, whereas a-v O2 reflects
an interaction between blood flow and myocyte V̇O2, where
the latter can be impaired by metabolic inertia (16).
CO responses in diabetic subjects have been shown to be
similar to nondiabetic subjects after 5 min of submaximal
cycling (2). However, before the present study, no data describing the rate of adjustment of CO before these responses
plateauing during steady-state exercise were available. In
addition, this is the first time where V̇O2 kinetics and CO
responses have been measured simultaneously in the same
subjects during the same exercise protocols. The present
findings found no differences in CO between groups at any
time point during exercise, and HR kinetics were also similar. In addition, the change in CO from the onset (30 s) to
240 s of exercise was significantly greater, and not lower, at
moderate intensities in the group with type 2 diabetes compared with the two nondiabetic control groups. Because this
period is closely associated with phase 2 of the V̇O2 response, these findings suggest that the slowed V̇O2 response
is not due to a slow adjustment of CO.
The dynamic response of V̇O2 might be impaired by a
slowing of the rise in O2 consumption by contracting muscle, resulting in a slower increase in a-v O2. In support of
this is evidence of a lower mitochondrial content (27) and
abnormal mitochondrial function (15,27) in skeletal muscle
of subjects with type 2 diabetes compared with healthy
controls. However, in the present study, the a-v O2 was not
different during any of the three submaximal exercise intensities investigated between type 2 diabetes and nondiabetic controls. In addition, the changes in a-v O2 difference
from rest to the onset of exercise (30 s) and from 30 to 240 s
of exercise were not different between groups (Fig. 1). This
suggests that the ability of active muscle to extract O2 during
exercise might not be impaired in type 2 diabetes. Our
findings support the results by Baldi et al. (2), who also
reported similar a-v O2 responses after 5 min of submaximal
cycling in diabetic and nondiabetic subjects.
In the absence of any apparent cardiac dysfunction and
similar a-v O2 responses, it is likely that the slowed V̇O2
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FIGURE 2—Representative oxygen uptake responses during cycling exercise at intensities equivalent to 50% VT in an individual with type 2
diabetes, a heavy control, and a lean control. The individual with type 2 diabetes has a slower T2 and MRT (T2 = 56.2 s, MRT = 48.1 s) than the
heavy control (T2 = 17.1 s, MRT = 30.1 s) and lean control (T2 = 16.9 s, MRT = 32.4 s).

kinetic responses are, at least in part, linked to a maldistribution and/or slowed dynamic adaptations of blood flow to
the active muscles. The latter is supported by observations of
significantly lower limb blood flow responses after several
minutes of submaximal cycling in uncomplicated type 2 diabetes (17). This would help explain the more rapid decline in
muscle microvascular PO2 observed in diabetic rats compared
with control rats (6) and the transient ‘‘overshoot’’ in NIRSmeasured [HHb] at the onset of cycling exercise above the
steady-state levels in humans with uncomplicated type 2 diabetes. (4). Collectively, these findings suggest that the rate of
O2 delivery is slowed relative to the rate of O2 consumption
by the active muscles in type 2 diabetes. However, steadystate blood flow measurements (17) do not demonstrate the
dynamic adaptations before these responses, and thus, further
studies are needed to explore if muscle blood flow kinetics
are altered in diabetes.
The present findings are clinically important. The slower
O2 uptake adaptations to light–moderate exercise intensities
in diabetes imply a greater reliance on anaerobic metabolism
leading to more rapid fatigue and a lowering of exercise tolerance. These effects might contribute to the perception of
daily light routine activities (i.e., climbing stairs, etc.) as being more difficult, as observed in uncomplicated type 2 diabetes (12), and they might reduce the willingness to adopt
a more active lifestyle.
Limitations. Previous diabetic women studied in regard
to V̇O2 kinetics were premenopausal (4,7,23). In contrast, in
the present study, both premenopausal and postmenopausal
women were studied and menopause may affect exercise
responses by reducing endothelial-dependent vasodilation
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(29). However, this is unlikely to have introduced bias in the
results given that the distribution of premenopausal and
postmenopausal women was similar in the three groups. The
BMI values were numerically larger (although not significantly different) in subjects with type 2 diabetes compared
with heavy controls. It is unlikely that these differences in
BMI affected our results given that ‘‘obesity’’ per se did not
alter exercise responses among nondiabetic lean and heavy
participants. The peak V̇O2 during the incremental test was
numerically lower (but not significantly different) than the
V̇O2 at the end of the high-intensity constant-load test in the
diabetic participant. Although others have also reported
these responses (23), these data might question whether the
incremental test evoked ‘‘peak’’ or maximal responses in
diabetic participants. Although only two of the nine diabetic
subjects reached their predicted maximum HR, eight of the
nine subjects reached peak RER values in excess of 1.1, and
their V̇O2 values increased G2 mLIkgj1Iminj1 with an increase in work rate (i.e., eight of nine diabetic participants
reached V̇O2max (9)). Thus, we are confident that diabetic
participants reached maximal responses.

CONCLUSIONS
In summary, these findings confirm that exercise tolerance and the dynamic response of oxygen uptake during
low to moderate exercise are impaired in type 2 diabetes.
These effects, however, are not related to CO because its
response during exercise was not slower or smaller in type 2
diabetes. These findings are limited to females with uncomplicated type 2 diabetes, and further research is required
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to establish the influence of CO on exercise V̇O2 when
comorbidities are present and in male subjects with type 2
diabetes.
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